AC
Applied Clinical Trials
ACT Brief: APAC Trial Advantages, Learning From Setbacks, and Sunharbo Stroke Prevention Approval
0:00-1:41
In today’s ACT Brief, we examine why APAC is attractive for global Phase III programs, how clinical research professionals can turn a failed pivotal trial into a redesigned success, and how FDA approved Sunharbo to reduce recurrent stroke risk.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8975608
Published
November 11, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#actbrief #apactrialadvantages #sunharbostrokeprevention #lifesciences
